Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice
Sura-vec inhibits the VEGF pathway by which new, leaky blood vessels grow and contribute to the accumulation of fluid in the retina, as described by the company To view or add a comment, sign in Merck is advancing the frontier in immune-mediated inflammatory diseases by launching three new Phase 2b trials for Tulisokibart, an innovative anti-TL1A monoclonal antibody
MOST POPULAR Beyond HEAL A powerful duo studied for injury recovery, tissue repair, and mobility support
either very low or very high adiposity impairs fertility
the choice depends on clinical fit, budget, and provider recommendation
Protective effects of a natural herbal compound quercetin against snake venom-induced hepatic and renal toxicities in rats